Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...
The Motley Fool on MSN10d
Down 93%, Is It Finally Time to Buy Moderna?In addition to its COVID-19 vaccine, Moderna markets an RSV vaccine that earned approval in 2023. Pfizer has more resources ...
As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...
Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
A handful of states are targeting the technology at the same time the Trump administration is cutting research funding and ...
Pregnant women can get the COVID-19 vaccine without any fear of causing birth defects in their unborn child, a new st ...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback